RA Capital Healthcare Fund LP's Sale of Vor Biopharma Inc. Common Stock

RA Capital Healthcare Fund LP, a significant shareholder and director of Vor Biopharma Inc., has filed a notice of its intention to sell 126,887 common shares of Vor Biopharma Inc. The shares were acquired through private financing transactions between February 2019 and June 2020. The aggregate market value of the shares to be sold is approximately $3,687,336.22. Additionally, RA Capital Healthcare Fund LP recently sold 42,933 common shares on October 15, 2025, for a total of $1,311,852.16. The sale is expected to occur on or around October 16, 2025, and will be facilitated by BTIG, LLC. This filing highlights significant activity by a major shareholder, indicating potential changes in the company's ownership structure.